Fact Sheets

Stelis December Post-02 (1)

Stelis Biopharma’s CDMO partner receives approval for a key ANDA from the USFDA

Stelis Biopharma is pleased to announce that its CDMO partner has received ap

no
Stelis_FDA_Banner1

Stelis’ flagship facility receives Establishment Inspection Report from USFDA for Drug Product Manufacturing

Stelis Biopharma Limited, the biologics arm of Strides Pharma Science Limited

no
Facility

Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities

Stelis Biopharma, the biologics arm of Strides Pharma Science announced that

no
Stelis Next Phase

COVID-19 Impact Report and Response

January 2021 In 2020 the Coronavirus pandemic has, unsurprisingly, proved to

no
i-picked hack of a time

I Picked A Heck Of A Time

A new CEO’s observations on managing a fast-growing, fully integrated biophar

no
Unit 2 Bangalore

Stelis starts next phase of investment into its biologics manufacturing facility

This phase sees the CDMO start work on installing two 2,000-L single-use bior

no
south-bangalore-1

Unit 1 – Bangalore, India

State-of-the-art process and analytical development facilities for small-scal

no
north-bangalore

Unit 2 – Bangalore, India

Integrated state-of-the-art manufacturing facility leverages microbial and ma

no
Outsourcing Formulation

Meeting Demand for Biologics & Specialty Drugs

A company that provides insurance and investment-related products and service

no
Overcoming Biologic

Overcoming Biologic Drug Formulation Hurdles

A company that provides insurance and investment-related products and service

no

It seems we can't find what you're looking for.